# Efficacy of Topical Lidocaine/Prilocaine in Pain Management in Pleurocentesis

> **NCT05984264** · PHASE4 · UNKNOWN · sponsor: **Assiut University** · enrollment: 118 (estimated)

## Conditions studied

- Pleural Effusion

## Interventions

- **DRUG:** lidocaine 2.5% and prilocaine 2.5% cream in pain management before pleurocentesis.

## Key facts

- **NCT ID:** NCT05984264
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2023-09
- **Final completion:** 2023-12
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2023-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05984264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05984264, "Efficacy of Topical Lidocaine/Prilocaine in Pain Management in Pleurocentesis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05984264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
